Glaxis Capital Management, LLC Novo Nordisk A S Transaction History
Glaxis Capital Management, LLC
- $23.3 Million
- Q3 2024
A detailed history of Glaxis Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Glaxis Capital Management, LLC holds 3,500 shares of NVO stock, worth $306,775. This represents 1.78% of its overall portfolio holdings.
Number of Shares
3,500
Previous 10,000
65.0%
Holding current value
$306,775
Previous $1.43 Million
70.85%
% of portfolio
1.78%
Previous 2.66%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,957Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.77 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.26 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.26 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.17 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.07 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $198B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...